Overview

An Efficacy and Safety Study of Theraflu Night Powder as Oral Solution for Cold and Flu

Status:
Withdrawn
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the short term efficacy of the Theraflu Night powder for oral solution in the Russian population in "Short term relief of the symptoms of colds, chills and influenza, including mild to moderate pain, fever and nasal congestion".
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Acetaminophen
Ascorbic Acid
Dextromethorphan
Maleic acid
Oxymetazoline
Pharmaceutical Solutions
Pheniramine
Phenylephrine
Vitamins